USANA Health Sciences, Inc. (USNA)
NYSE: USNA · Real-Time Price · USD
13.54
+0.30 (2.27%)
At close: Nov 16, 2026, 4:00 PM EST
13.81
+0.27 (1.99%)
After-hours: Nov 16, 2026, 7:30 PM EST

USANA Health Sciences Income Statement

Millions USD. Fiscal year is Feb - Jan.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Jan '26 Dec '24 Dec '23 Dec '22 Jan '22
905.58925.26854.5921.01998.61,186
Revenue Growth
-0.78%8.28%-7.22%-7.77%-15.83%4.57%
Cost of Revenue
205.9200.85161.21176.69193.89217.9
Gross Profit
699.68724.41693.29744.32804.71968.57
Selling, General & Admin
660.86673.54618.72651.25697.1798.37
Operating Expenses
660.86673.54618.72651.25697.1798.37
Operating Income
38.8250.8674.5793.07107.61170.19
Interest Expense
-0.4-0.84-0.28-0.26-0.19-0.06
Interest & Investment Income
2.172.4211.329.643.792.52
Other Non Operating Income (Expenses)
1.922.52-1.010.01-2.59-2.01
EBT Excluding Unusual Items
42.5154.9684.59102.45108.62170.64
Merger & Restructuring Charges
-6.46-6.46-8.24---
Impairment of Goodwill
-35.53-6.39----
Asset Writedown
-0.58-0.58----
Pretax Income
-0.0641.5376.35102.45108.62170.64
Income Tax Expense
29.4230.0534.2938.6739.2754.14
Earnings From Continuing Operations
-29.4811.4842.0663.7969.35116.51
Minority Interest in Earnings
8.28-0.72-0.03---
Net Income
-21.210.7642.0363.7969.35116.51
Net Income to Common
-21.210.7642.0363.7969.35116.51
Net Income Growth
--74.40%-34.11%-8.02%-40.48%-6.54%
Shares Outstanding (Basic)
181919191920
Shares Outstanding (Diluted)
181919191920
Shares Change
-1.93%-3.07%-0.95%0.18%-5.08%-4.29%
EPS (Basic)
-1.150.582.203.313.605.78
EPS (Diluted)
-1.150.582.193.303.595.73
EPS Growth
--73.52%-33.64%-8.08%-37.35%-2.22%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Jan '26 Dec '24 Dec '23 Dec '22 Jan '22
Free Cash Flow
29.548.5350.9256.1593.5108.46
Free Cash Flow Per Share
1.600.462.662.904.845.33
Gross Margin
77.26%78.29%81.13%80.81%80.58%81.64%
Operating Margin
4.29%5.50%8.73%10.11%10.78%14.34%
Profit Margin
-2.34%1.16%4.92%6.93%6.94%9.82%
Free Cash Flow Margin
3.26%0.92%5.96%6.10%9.36%9.14%
EBITDA
71.4483.4289.11105.77121.01183.23
EBITDA Margin
7.89%9.02%10.43%11.48%12.12%15.44%
D&A For EBITDA
32.6332.5614.5412.713.3913.04
EBIT
38.8250.8674.5793.07107.61170.19
EBIT Margin
4.29%5.50%8.73%10.11%10.78%14.34%
Effective Tax Rate
-72.36%44.91%37.74%36.15%31.72%
Advertising Expenses
-43.164.974.765.0512.4
SEC Filings: 10-K · 10-Q